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In the recent years, it has been noted that microorganisms with acquired
resistance to almost all available potent antibiotics are increasing worldwide. Hence,
the use of antibiotics in every clinical setup has to be organized to avoid irrational
use of antibiotics. This study was aimed to establish the pattern of antibiotic
sensitivity and relevance of antimicrobial resistance in aerobic Gram-negative
bacilli. A total of 103 aerobic Gram-negative bacteria namely Escherichia coli,
Klebsiella pneumoniae, Enterobacter spp., Citrobacter koserii, Proteus spp., and
Pseudomonas aeruginosa were collected from tertiary care centers around Chennai.
Kirby–Bauer Disk Diffusion test and study for genes of cephalosporin, carbapenem,
and aminoglycoside resistance were done. A descriptive analysis of the data on
altogether 103 clinical urine isolates was performed. All strains showed suscepti-
bility to colistin. The frequency of genes encoding 16S rRNA methylases armA and
rmtB were 7.8% and 6.8%, respectively. Among metallo-β-lactamases, blaVIM,
blaIMP, and blaNDM-1 were detected in 6.8%, 3.8%, and 3.8%, respectively. One
E. coli strain harbored blaSIM-1 gene. Cumulative analysis of data suggested that
30% of the strains carried more than one resistance gene. The current research
evidenced the increasing frequency of resistance mechanisms in India. Combined
approach of antibiotic restriction, effective surveillance, and good infection control
practices are essential to overcome antibiotic resistance.
Keywords: multidrug resistance, ESBL, MBL, armA, rmtB
*Corresponding author; E-mail: sangeetha556@gmail.com
Acta Microbiologica et Immunologica Hungarica 65 (1), pp. 107–118 (2018)
DOI: 10.1556/030.64.2017.027
First published online September 1, 2017
1217-8950/$20.00 © 2017 Akadémiai Kiado´, Budapest
Introduction
Enterobacteriaceae and non-fermentative Gram-negative Pseudomonas and
Acinetobacter species are responsible for majority of hospital- and community-
acquired infections globally due to their accelerated antibiotic resistance and
difﬁculty in treatment by conventional antibiotics. Colistin and polymyxin B have
become the only drugs of choice for serious infections caused by the beta-
lactamases-producing aerobic Gram-negative bacilli. The incidence of infections
caused by these organisms has increased in recent years [1]. To minimize the
spread of these bacteria in the community, there is an increasing need for clinical
laboratory to identify and characterize the strains up to the molecular level
especially for drug resistance. Moreover, the inappropriate use of antibiotics
and acquisition of mobile genetic elements by horizontal transfer may result in
a “superbug,” with resistance to all licensed antibiotics. Deliberate and per-
petual surveillance studies are warranted since the epidemiology of beta-
lactamase-producing bacteria have become complex. In India, many studies have
identiﬁed disseminated multidrug resistance among Gram-negative bacilli due to
extended-spectrum beta-lactamases (ESBL) and carbapenamases [1].
Owing to the dramatic increase in bacterial resistance to β-lactam antibiotics,
aminoglycosides have become the substitutes for the therapeutics due to their
broad antimicrobial spectrum and also their synergistic effect in association with
other antibiotics. Increased prescription of aminoglycosides for therapy accounts
for the growing resistance to aminoglycoside antibiotics. Three groups of enzymes
produced by bacteria confer aminoglycoside resistance namely, acetyltransferases,
nucleotidyl transferases, and phosphotransferases, which inactivate gentamicin
(GEN) and tobramycin (TOB). However, recently plasmid-mediated 16S rRNA
methylases have emerged which confer remarkably high-level resistance to
arbekacin, amikacin (AK), TOB, and GEN (3) through post-transcriptional
methylation of the aminoglycoside-binding site leading to the loss of afﬁnity [2].
Until now, 10 plasmid-mediated 16S rRNA methylases (armA, rmtA, rmtB,
rmtC, rmtD, rmtE, rmtF, rmtG, rmtH, and npmA) have been identiﬁed in at least
30 countries worldwide [2–11]. Since the 16S rRNA methylase genes are
frequently located on plasmids, there is an increased probability of other resistance
mechanisms to interplay, thus leading to multidrug resistance. In particular,
very recently, this coexistence is seen with genes encoding ESBL and metallo-
β-lactamases (MBL). As a consequence, those strains remain resistant to ami-
noglycosides, beta-lactams, and carbapenems.
Limited studies that are available in India show the percentage of 16S rRNA
methylases-mediated aminoglycoside resistance in Gram-negative isolates.
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Nevertheless, surveillance in Southern and Eastern parts of Europe reported
approximately 10%–50% aminoglycoside resistance in invasive strains with
consistent increase every year. Moreover, armA and rmtB are often identiﬁed
genes among the methylases in Gram-negative bacilli from East Asia and South
America [3]. Hence, we intended to investigate the prevalence of armA and rmtB
genes among the ESBL- and/or MBL-producing Enterobacteriaceae and
non-fermenting Gram-negative bacilli prospectively recovered from patients at
multiple centers in Chennai.
Materials and Methods
Clinical strains
About 103 aerobic Gram-negative urinary isolates resistant to at least one
antibiotic were collected from multicenters, in and around Chennai, Tamil Nadu.
Identiﬁcation of bacterial isolates was done to the species level by cultural
characteristics and biochemical reactions by conventional methods.
Antimicrobial susceptibility testing
The antimicrobial susceptibility testing was carried out on all strains by
Kirby–Bauer Disk Diffusion Agar method using commercial disks (HiMedia)
according to the criteria recommended by Clinical and Laboratory Standards
Institute (CLSI) [12]. The antibiotics tested were ampicillin (AMP), ciproﬂoxacin
(CIP), ceftazidime (CAZ), CAZ/clavulanic acid (CAC), piperacillin (PIP), AK,
GEN, TOB, imipenem (IPM), meropenem (MEM), cefoxitin (CX), aztreonam
(AZT), cefepime (CPM), and PIP/tazobactam (PTZ). All isolates were tested for
colistin susceptibility by E-test colistin strip (ranging from 0.016 to 256 mg/ml)
according to the manufacturer’s guidelines (Lioﬁlchem, Italy). The minimum
inhibitory concentration (MIC) was read at the point of complete inhibition of all
growth, including hazes. The interpretive criteria used were those established in
CLSI. Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853
were used as control strains for antibiotic susceptibility testing and E-test.
Phenotypic screening for ESBLs and MBLs
ESBL production was detected by double-disk synergy test as recommended
by the CLSI guidelines (CLSI, 2010). The strains showing any synergy between
CAZ/CAC disk and CPM/CAZ disk were considered to be ESBL producer [13–17].
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Combined disk test with IPM/MEM–EDTA-impregnated disk was performed for
MBL screening as previously described by Arunagiri et al. [18].
Isolation of genomic DNA
A single colony was inoculated into 5-ml Luria–Bertani broth and incubated
with shaking at 37 °C for 20 h. Overnight culture was harvested by centrifugation
for 5 min and the pellet was resuspended in 500 μl distilled water. The cells were
lysed by heating at 95 °C for 5 min and centrifuged for 1 min. After centrifugation,
5 μl of supernatant was used for PCR ampliﬁcation.
Genotypic ESBL and MBL characterization
Ampliﬁcation of DNAwas performed in a thermal cycler for the detection of
blaTEM, blaSHV, and blaCTX-M ESBLs and blaVIM, blaIMP, blaSIM-1, blaGIM-1,
blaSPM-1, and blaNDM-1 MBLs. Primers, PCR amplicon size, and annealing
temperature were indicated in Table I. PCR-ampliﬁed products were subjected
to electrophoresis on a 1.5% agarose gel, stained with ethidium bromide, and
visualized under UV light to observe the anticipated PCR product.
Detection of armA and rmtB genes
The armA and rmtB genes were detected by PCR as described by Doi and
Arakawa [3]. Primers for armA and rmtB are described in Table I. Primers for armA
detected a region of 315 bp and rmtB detected a region of 173 bp. PCR ampliﬁcation
was done; the products were electrophoresed in 1.5% agarose gels, and visualized
under UV light. The cycling conditions were initial DNA denaturation at 95 °C for
5 min, 35 cycles of denaturation at 95 °C for 30 s, annealing as given in Table I,
extension at 72 °C for 1 min, and a ﬁnal elongation at 72 °C for 5 min.
Results
During the study period, 103 clinical isolates resistant to at least one antibiotic
were collected from clinical urine samples from multicenters, in and around Chennai,
Tamil Nadu. Samples included 66 (64.1%) females and 37 (35.9%) males whose age
group ranged from 1 to 68 years with mean age of 38.4± 19.1 years. Isolates were
distributed as E. coli (73.7%), Klebsiella pneumoniae (10.6%), P. aeruginosa (9.7%),
Enterobacter (2.9%), Citrobacter koseri (1.9%), and Proteus spp. (0.9%).
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Antimicrobial susceptibility testing
All the 103 isolates were sensitive to colistin by E-test method with MIC≤
2 μg/ml and were found resistant to AMP. The resistant trend decreased with respect
to MEM, CIP, PIP, AZT, CPM, CAZ, and GEN substantially. More than 50% were
resistant to ﬁve antibiotics, such as AMP, MEM, CIP, PIP, AZT, and CPM, and
more than 50% were sensitive to GEN, CX, AK, CAC, TOB, PTZ, and IPM.
β-lactamase characterization
Of the 103 isolates, 57 (55.3%) were positive for ESBL screening as it
showed synergy between CAZ/CAC and CPM/CAZ disk and 14 (13.5%) strains
were positive for MBL screening since they exhibited signiﬁcant zone size
enhancement with the ethylenediaminetetraacetic acid-impregnated disk when
compared with the IPM/MEM disk. Ten isolates showed positive for both ESBL
and MBL screening. The most prevalent gene was blaCTX-M as it appeared among
the clinical isolates as single resistance gene (16.5%) or in combination with other
resistance determinants (23.3%), such as blaTEM, blaVIM, blaSHV, blaIMP, and
blaNDM-1. The second most prevalent genes were TEM and SHV present alone in
6.7% and 3.8%, respectively. Genes blaVIM, blaIMP, blaSIM-1, and blaNDM-1 were
found in 5.8%, 2.9%, 0.9%, and 3.8% of strains, respectively, alone or in
combination with other resistance genes. Altogether, 38/103 (36.8%) were found
to be negative for any gene, which constitutes of 35 E. coli and 3 K. pneumoniae.
Prevalence of methylase genes
Out of 103 isolates, only 12 (11.6%) were harboring methylase gene armA
and rmtB and only four of them were presented as individual gene. The remaining
eight isolates were positive for these genes together with other beta-lactamase
resistance genes.
Discussion
Beta-lactamase production has been identiﬁed as one of the most important
mechanism of resistance among Gram-negative strains leading to global threat.
Recently, the high prevalence of aminoglycoside resistance mechanisms among
these strains is alarming. In this study, resistance rates of the Gram-negative
isolates to GEN were more than 50.0%, but resistance to AK and TOB were
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relatively low. Yu et al. [23] reported similar resistance to GEN among the E. coli
isolates but showed higher resistance to TOB.
The armA gene was initially sequenced from a Citrobacter freundii strain in
Poland but ﬁrst characterized from K. pneumoniaeBM4536 in France in 2000, and
the rmtB gene was ﬁrst identiﬁed in Serratia marcescens S-95 isolated from a
Japanese patient in 2002. Since then these two genes have been found in
Enterobacteriaceae, P. aeruginosa, and Acinetobacter baumannii in Asia-Paciﬁc
region [23–26]. In this study, the overall prevalence rate of 16S rRNA methylase
genes armA and rmtB alone/in combination with beta-lactamase genes was 11.6%.
This is higher than the percentage of armA and rmtB previously reported in a
Chinese study (5.4%), a Taiwanese study (0.4%), and a study from Shanghai,
China (3.4%) [24, 26]. Very few studies have reported armA and rmtB genes from
India [26]. Unlike other reported studies, the data from this study showed armA to
be more prevalent than rmtB gene [24, 28, 29].
In this study, 16S rRNA methylase genes have been identiﬁed to be linked
with other beta-lactamase resistance determinants blaTEM, blaCTX-M, blaSHV,
blaVIM, blaIMP, and blaNDM-1, and cotransferred with other resistance determinants
on self-transferable plasmids to recipients by conjugation as reported previously
[23–25, 27], thus, conferring resistance to multiple antibiotics. The armA gene
was detected as a single gene in one (0.9%) K. pneumoniae and two (1.9%)
P. aeruginosa strains. However, in various combinations with other beta-
lactamase genes, it was seen in four (3.9%) E. coli strains and one (0.9%)
K. pneumoniae strain. Similarly, rmtB gene was detected as a single gene in one
(0.9%) P. aeruginosa strain but four (3.9%) E. coli and one (0.9%) K. pneumoniae
strains harbored this gene in combination with other beta-lactamase gene. Overall,
out of the 14 isolates carrying 16S rRNA methylases, one (0.9%) strain harbored
blaCTX-M, blaTEM, blaNDM-1, armA, and rmtB genes and was highly resistant to all
the tested antibiotics except colistin. Enterobacter, C. koseri, and Proteus spp. did
not carry any 16S rRNA methylase gene either alone or in combination.
Numerous previous studies have reported ESBL production ranging from
68% to 72% [30, 31] and MBL production 28% to 42% [32, 33] among the Gram-
negative strains. In this study, genotypic screening for ESBLs and MBLs identiﬁed
55.3% strains carried at least one ESBL gene and 13.5% strains carried at least one
of the MBL gene by PCR. The presence and diversity of ESBLs and MBLs in
different isolates as a single gene and in association with other resistance genes are
shown in Table II. Among the ESBLs, CTX-M was the most common gene found
(16.5%) both individually and in combination (22.3%), followed by TEM-type
ESBLs (9.7%) individually and (15.5%) in association and SHV-type ESBLs
(4.8%) individually and (1.9%) in association. PCR for MBLs showed blaNDM-1
and blaVIM (6.7%) to be the most dominant type found followed by blaIMP (3.8%)
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and blaSIM-1 (0.9%) gene similar to a study by Somily et al. [34]. One E. coli strain
was found to harbor SIM-1 gene and another E. coli strain, which was identiﬁed
with high resistance to all the antibiotics except colistin was positive for blaCTX-M,
blaTEM, blaNDM-1, armA, and rmtB genes. Similarly, the emergence of the
multidrug-resistant E. coli and K. pneumoniae strains producing both ESBLs and
16S rRNA methylases was identiﬁed in a previous study in Taiwan. Thus, the
antibiotic resistance in Gram-negative strains lead to increased morbidity, mortality
at hospital settings as revealed by surveillance studies from Europe, Asia-Paciﬁc
region, Latin America, and North America over the last 3–5 years [35].
The antibiotic resistogram showed an increasing resistance to various
antibiotics. However, in contrast to the other reported studies, colistin was the
most active drug with 100% sensitivity followed by IMP and PIP/PTZ [36].
Hence, colistin is the only choice available for the treatment of these multidrug-
resistant strains, but it should be used in accordance with the antimicrobial
consumption policy to prevent the dissemination of drug-resistant clones.
AMP showed highest percentage of resistance followed by CIP and MEM
(Figure 1). Several published reports have documented reduced susceptibility to
MEM among Gram-negative strains. Kaul et al. [37] reported increased carba-
penem resistance in Gram-negative bacilli. A study by Srinivasa Rao et al. [38] has
reported high-level resistance (>75%) to both carbapenem and other antibiotics
routinely used for the treatment of Gram-negative bacilli.
Conclusions
Comparatively, high prevalence of plasmid-mediated armA and rmtB genes
was described in this study among clinical aerobic Gram-negative isolates from
urine samples from multicenter in Chennai. The majority of 16S rRNA methylase
gene-positive isolates coproduced CTX-M, TEM, SHV-type ESBLs and IMP,
VIM, NDM-1-type MBLs. Thus, both horizontal gene transfer and clonal spread
Figure 1. PCR ampliﬁcation of 16S rRNA methylase genes
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may occur leading to widespread dissemination of the armA and rmtB genes. A
very rare gene is blaSIM and it is usually found in Acinetobacter spp., but in this
study, we have identiﬁed the presence of blaSIM-1 in E. coli, which may indicate
the dissemination of the blaSIM-1 gene.
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